The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
Initiatives include scholarships, STEM initiatives, and healthcare capacity-building programmes supporting women and girls across 52 countries
IIT Kanpur team has developed computational framework to map how cell signals influence gene activity across tissues
The six-part webinar series aims to enhance awareness, diagnosis, and management of autoimmune diseases
The ultrasound-based AI imaging platform is designed to support rapid fracture detection and soft tissue injury assessment in emergency care settings
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
The once-daily oral therapy is the first and only tyrosine kinase 2 (TYK2) inhibitor approved in the European Union for this indication, marking a significant expansion of its immunology portfolio
Expands manufacturing push & locks in major growth deals
Initiative launched with Tata 1mg to benefit 70,000 people across 70 remote villages in Kalahandi region
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
